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Available online 5 February 2016AbstractPurpose: We describe a case of transient visual loss following cataract surgery with unpreserved intracameral lidocaine.
Method: A 50-year-old man with posterior polar cataract underwent phacoemulsification. Following capsulorhexis and hydrodelineation with
0.5 cc of unpreserved lidocaine 1%, a portion of fluid reached behind the crystalline lens and caused the posterior capsule rupture. Cataract
extraction and anterior vitrectomy were performed. Anesthetic administration was repeated to relieve the discomfort felt by the patient. A three-
piece hydrophobic acrylic intraocular lens was implanted in the ciliary sulcus.
Results: On the first postoperative morning, the patient's vision was recorded as having no light perception. The relative afferent pupillary defect
(RAPD) was found to be 4þ. The retina and optic nerve head appeared normal. In the afternoon, the visual acuity (VA) was improved to 3-m
count-finger. On the second postoperative morning, the patient's VA was improved to 4/10. On the third postoperative day, his VA returned to
normal at 20/20 without RAPD.
Conclusion: In the event of posterior capsular rupture, to reduce retinal toxicity risks, intracameral lidocaine should not be repeated.
Copyright © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Using unpreserved intracameral lidocaine as an adjunct
anesthetic to topical anesthesia has become a widespread
technique in cataract surgery. While safety and efficacy of
intracameral lidocaine is well-documented, retinal toxic ef-
fects and transient visual loss caused by lidocaine have been
suggested.
We report a case of transient, complete visual loss,
following posterior polar cataract surgery with posterior
capsular rupture.* Corresponding author. Farabi Eye Research Center, Tehran University of
Medical Sciences, Qazvin Square, Tehran, Iran.
E-mail address: panvari@razi.tums.ac.ir (P. Anvari).
Peer review under responsibility of the Iranian Society of Ophthalmology.
http://dx.doi.org/10.1016/j.joco.2015.12.005
2452-2325/Copyright © 2016, Iranian Society of Ophthalmology. Production and ho
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Case report
A 50-year-old man presented to our clinic complaining of
blurred vision for one year in his right eye. Preoperative best-
corrected visual acuity was 10/20. Slit-lamp examination
revealed a posterior polar cataract. His intraocular pressure
and other ocular examinations including relative afferent pu-
pillary defect (RAPD) were unremarkable. He was accord-
ingly scheduled for phacoemulsification cataract surgery.
A small-incision cataract surgery was performed under
topical anesthesia and intracameral lidocaine. Following cap-
sulorhexis and hydrodelineation with 0.5 cc-unpreserved
lidocaine 1%, a portion of fluid reached behind the crystal-
line lens and caused the posterior capsule rupture.
Cataract extraction and anterior vitrectomy were per-
formed. During the anterior vitrectomy procedure, the patient
experienced an intense pain. This prompted us to repeat the
anesthetic.sting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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130 B. Eshraghi et al. / Journal of Current Ophthalmology 27 (2015) 129e131An additional 0.5 cc of lidocaine 1% was administered to
relieve his discomfort. A three-piece hydrophobic acrylic
(HOYA) e intraocular lens (IOL) was placed in the ciliary
sulcus. At the conclusion of surgery, the eye was patched, and
the patient was discharged.
On the first post-operative morning, the patient complained
of not being able to see anything. His vision was recorded as
having no light perception. The RAPD was found to be 4þ.
The fundus was examined under full pupillary dilation. The
retina appeared normal, and the optic disc was not edematous.
In the afternoon, the patient's visual acuity (VA) was improved
to 3-m count-finger. On the second postoperative morning, the
patient's VA was improved to 4/10. Vision assessment on the
early morning of the third postoperative day was surprising.
The patient's VA had improved to 20/20 without RAPD, and
all other ocular examinations were normal.
Discussion
The preferred technique for cataract surgeons in the United
States is topical anesthesia (37%; range 22e63%). In a survey
conducted by David Learning,1 76% of respondents preferred
using topical anesthesia with intracameral lidocaine injection.
Intracameral unpreserved lidocaine augments analgesia and
significantly decreases intraoperative pain perception. Lido-
caine is a useful adjunct, particularly in cases involving pu-
pillary manipulation and peripheral iridectomy.
While lidocaine has been reported to be safe and effec-
tive,2,3 temporary visual loss4e6 and retinal toxicity4,6
following the use of intracameral lidocaine have been high-
lighted in recent reports. An increased possibility of adverse
effects of lidocaine on the retina and optic nerve is introduced
in the event of compromise to the posterior lens capsule.4
Our patient had experienced transient visual loss while
receiving intracameral lidocaine and had an associated pos-
terior capsule rupture, which has an incidence of between
26% and 36% in posterior polar cataract surgeries.7,8 Nor-
mally, during cataract surgery, the lens capsule, zonules, and
vitreous humor have a barrier effect against instilled intra-
cameral lidocaine, and hence, the retina will not be affected.
Pars plana lensectomy and vitrectomy facilitate the diffusion
of the lidocaine into the posterior chamber.4
Gills et al.9 reported amaurosis in four patients following
the use of intracameral lidocaine, and in each case, the
posterior capsule was not intact. All four patients recovered
completely within hours. Hoffman and Fine4 reported on a
patient with complete visual loss after intracameral lidocaine
to repair a traumatic corneal graft dehiscence with a capsular
tear, which was fully recovered several hours postoperatively.
Falzon et al.10 reported a case of transient, complete loss of
vision following phacoemulsification with an intracameral
ophthalmic viscosurgical device (OVD) and lidocaine solu-
tion complicated by posterior capsule rupture, which
improved to 20/80 after one day and 20/25 in one week.
Full recovery of visual acuity in our patient required three
days, in contrast to the majority of reports (Table 1) with
capsular tear4,9 that had complete VA improvements within
131B. Eshraghi et al. / Journal of Current Ophthalmology 27 (2015) 129e131hours. The longer time span in recovery of VA in our patient
might be explained by a higher volume of lidocaine that was
diffused in the vitreous.
Lincoff et al. reported three cases of inadvertent intravitreal
lidocaine injections,6 all of which resulted in immediate decreased
vision, with recovery occurring within four hours. Schechter5
reported a case of inadvertent intraocular lidocaine injection
with an immediate visual acuity of NLP (no light perception) that
improved to 20/40 after one day and to 20/20 in one week.
Toxicity of lidocaine to rodent retinal ganglion cells has
been documented.11 Lidocaine affects the pigment transport in
retinal cells of crayfish and frogs. This inhibition is probably
due to an anesthetic-induced disruption of intercellular ionic
balance and increased plasma membrane permeability.
Furthermore, intravitreal injection of lidocaine has also been
investigated in cats, rabbits, and rats.6,12,13 In these animal
studies, the electroretinogram analyses revealed a reversible
reduction in the amplitude and extinguished b-waves which
fully recovered within 10e24 h. In cats, intravitreal injection
of lidocaine has been followed with vacuolization of nerve
layers and presence of microscopic lesions in synapses be-
tween horizontal, bipolar cells, and photoreceptors. In addi-
tion, histopathological retinal structure changes near the
injection sites have been detected.
One limitation of our study is that the patient did not
consent to perform the ERG and mfERG tests. However, in the
presence of positive RAPD, normal retinal examination, and
full recovery of vision, the most plausible cause of vision loss
would be attributed to lidocaine retinal toxicity. In view of the
above, when posterior capsular rupture occurs, it is wise not to
repeat intracameral lidocaine to minimize potential retinal
toxicity risks.
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